The densitometric analyses indicated that the average levels of activity of circulating MMP-2 and MMP-9 in breast cancer patients were significantly higher than control sera (P<0.0001), and suggest that serum measures of MMP-2 and MMP-9 activity may have diagnostic value for discriminating subgroups of breast cancer patients. This evidence concerns the gene MMP2 and breast carcinoma.